
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 213
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT03574415 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | ||
NCT02947815 | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm | ||
NCT05411887 | Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab | ||
NCT03029533 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | ||
NCT02946450 | Observational Study to Assess the Safety of Omnipure® Inj.(Iohexol) Contrast Media in CT Scanning Patients | ||
NCT04749173 | To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers. | ||
NCT06592495 | Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 | ||
NCT05304845 | Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects | ||
NCT02346045 | Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension | ||
NCT06212960 | Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines | ||
NCT06010589 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult Volunteers | ||
NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
NCT04592835 | To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003 | ||
NCT05207176 | Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various Ethnicities | ||
NCT05376969 | Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin | ||
NCT04014023 | Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities | ||
NCT04819932 | Pharmacokinetics and Safety of DWJ1451 in Healthy Adults | ||
NCT06508645 | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers | ||
NCT05083299 | Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate | ||
NCT03009721 | Observational Study to Investigate the Effectiveness and Safety of Olostar Tab in Patients With Essential Hypertension and Dyslipidemia | ||
NCT00845819 | Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies | ||
NCT05500898 | Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults | ||
NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
NCT05505994 | The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on Metformin | ||
NCT05321732 | The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy Adults | ||
NCT05614765 | Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex Treatment | ||
NCT03753477 | Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 | ||
NCT01964365 | Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and Fenofibric Acid in Healthy Male Volunteers | ||
NCT02665832 | Study of DWJ1351 in Healthy Male Volunteers | ||
NCT05737771 | To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination | ||
NCT04524052 | To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19 | ||
NCT06119945 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | ||
NCT06736587 | A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers | ||
NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
NCT01423526 | A Single Dose Study of DWP10292 in Healthy Male Subjects | ||
NCT04613895 | Treatment Effect According to Timing of Administration of DWP14012 40 mg | ||
NCT01653314 | Megavec 400 mg (Imatinib Mesylate) in Healthy Adult Male Volunteers | ||
NCT05812404 | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects | ||
NCT06141980 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
NCT04888715 | To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
NCT02622685 | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects | ||
NCT04521296 | Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo | ||
NCT05993247 | Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients | ||
NCT06119958 | Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects | ||
NCT03439020 | The Efficacy of Plastic Stent Anchoring to Reduce Migration of Metal Stent | ||
NCT04713176 | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients | ||
NCT03946592 | Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients |